Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹1,779 Cr₹1,905 Cr₹1,525 Cr₹1,326 Cr₹1,698 Cr

What is the latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,779 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹1,779 Cr
Mar2025₹1,905 Cr
Mar2024₹1,525 Cr
Mar2023₹1,326 Cr
Mar2022₹1,698 Cr

How is Total Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2026 ₹1,779 Cr
-6.62
Mar2025 ₹1,905 Cr
24.93
Mar2024 ₹1,525 Cr
14.97
Mar2023 ₹1,326 Cr
-21.91
Mar2022 ₹1,698 Cr -

Compare Total Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹113,589.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses